Close
Close
Treatment Database
5-(4-((2S,5S)-5-(4-chlorobenzyl)-2-methylmorpholino)piperidin-1-yl)-1H-1,2,4-triazol-3-amine
Trade Name not avaiable
Orphan Indication Idiopathic pulmonary fibrosis
USA Market Approval
USA Designation Date 25-02-2019
Sponsor OncoArendi Therapeutics SA
Zwirki i Wigury 101
Warsaw
More about Idiopathic pulmonary fibrosis
Free Newsletter
Related Videos
by Abidemi Uruejoma
482 views